Home
Live Updates
Inhibrx Announces Details of Presentation at 2022 ASCO Annual Meeting : comparemela.com
Inhibrx Announces Details of Presentation at 2022 ASCO Annual Meeting
/PRNewswire/ -- Inhibrx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development and an emerging pre-clinical pipeline,...
Related Keywords
Illinois ,
United States ,
Chicago ,
American ,
Santp Chawla ,
Bristol Myers Squibb ,
Prnewswire Inhibrx Inc ,
American Society Of Clinical Oncology ,
European Union ,
Inhibrx Inc ,
Nasdaq ,
Clinical Oncology ,
Annual Meeting ,
Exhibit Hall ,
Fast Track ,
Orphan Drug Designation ,
Media Contact ,
Inhibrx ,
Nc ,
comparemela.com © 2020. All Rights Reserved.